Our study, which leverages bioinformatics analysis of data from the TCGA and GEO databases and validation through patient tissue samples, identified that NeuroD1 regulates the degree of differentiation of pancreatic cancer cells, acts as a protective factor for pancreatic cancer, and is associated with a better prognosis. This evidence concerns the gene NEUROD1 and familial pancreatic carcinoma.